Adenosine triphosphate: Does it help cancer patients "get bigger and stronger"?

Journal of Clinical Oncology

Volumn 20, Issue 2, 2002, Pages 362-363

  Jatoi, Aminah ^a   Loprinzi, Charles L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; MEGESTROL ACETATE; PLACEBO;

ADVANCED CANCER; APPETITE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CANCER PATIENT; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ENERGY EXPENDITURE; GLUCONEOGENESIS; HYPERMETABOLISM; MUSCLE STRENGTH; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; WASTING SYNDROME; WEIGHT GAIN;

EID: 0037080145     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.2.362     Document Type: Editorial

References (12)

1. Beneficial effects of adenosine triphosphate on nutritional status in advanced lung cancer patients: A randomized clinical trial
2. Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small cell lung cancer
3. Current management of cancer-associated anorexia and weight loss
4. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
5. Body composition changes in patients who gain weight while receiving megestrol acetate
6. Generation of extracellular ATP in blood and its mediated inhibition of host weight loss in tumor-bearing mice
7. Inhibition of gluconeogenesis by extracellular ATP in isolated rat hepatocytes
8. Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancer
9. Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?
10. Analysis of the energy balance in lung cancer patients
11. The symptoms of advanced cancer: Relationship to age, gender, and performance status in 1000 patients
12. A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients: An Eastern Cooperative Oncology Group study